An assessment of periodontal health in patients with schizophrenia and taking antipsychotic medication

International Journal of Dental Hygiene
Abubekir EltasMustafa Özay Uslu

Abstract

Severe periodontal disease is prevalent among patients with schizophrenia and is caused by the side effect of their medication, poor dental hygiene and smoking. The objective of this study was to evaluate whether the rate of periodontal disease could be modulated by changing the salivary flow rate (SFR) because of the use of antipsychotic medications in patients with schizophrenia. Group A (n=33) included patients who used medications that may cause xerostomia, or dry mouth and Group B (n=20) included patients who used medications that may cause sialorrhea, an excessive secretion of saliva. The participants' periodontal status was assessed using the plaque index (PI), assessing bleeding on probing (BoP), probing pocket depth (PPD) and clinical attachment levels (CAL). The mean of PI and BoP was significantly higher in Group A than in Group B (P<0.001), but the PPD, CAL and decayed, missing and filled teeth (DMFT) scores were not significantly different in the two groups according to the statistical results (P>0.05). The researcher concluded that there is a high risk of periodontal disease among patients with schizophrenia, and there is an even higher risk of periodontal disease induced by medication that increased SFR. Preventi...Continue Reading

References

Sep 1, 1991·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·A H Friedlander, R P Liberman
Aug 1, 1989·The Journal of the American Dental Association·I D Mandel
Jan 1, 1987·Schizophrenia Bulletin·S R KayL A Opler
Apr 1, 1985·The Journal of the American Dental Association·P C FoxB J Baum
Nov 1, 1995·The Journal of the American Dental Association·H C Crow, J A Ship
Sep 20, 1993·Annals of the New York Academy of Sciences·M Navazesh
Dec 1, 1995·Community Dentistry and Oral Epidemiology·I F AngelilloA Amati
Mar 1, 1996·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·A ThomasC Kontis
Oct 29, 1998·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·E VelascoP Bullón
Feb 27, 1999·Journal of Clinical Periodontology·J R ElterS Offenbacher
Jan 1, 1992·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·B Hede, P E Petersen
Feb 24, 2001·International Dental Journal·B DoughanD M Bourgeois
Jan 24, 2002·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·S LewisE Treasure
May 31, 2002·The Journal of the American Dental Association·Arthur H Friedlander, Stephen R Marder
May 24, 2003·European Psychiatry : the Journal of the Association of European Psychiatrists·T RamonA Weizman
Oct 31, 2003·The New England Journal of Medicine·Robert Freedman
Sep 9, 2004·Acta Psychiatrica Scandinavica·R G McCreadieT Burns
Oct 2, 2004·Kidney International·Casper P BotsArie V Nieuw Amerongen
Mar 4, 2006·Psychopharmacology·Samir Kumar PraharajSachin Gandotra
Sep 11, 2007·Journal of Oral Rehabilitation·H Mese, R Matsuo
Jan 29, 2008·Expert Opinion on Pharmacotherapy·Nitin Gogtay, Judith Rapoport

❮ Previous
Next ❯

Citations

May 3, 2014·Social Psychiatry and Psychiatric Epidemiology·David BaumeisterValeria Mondelli
Dec 11, 2014·International Journal of Psychiatry in Medicine·Giovanni Fratto, Licia Manzon
May 11, 2016·Australian Dental Journal·L Slack-SmithA Durey
May 10, 2017·Issues in Mental Health Nursing·Dorte Buxbom Villadsen, Marie Toftdahl Sørensen
Jul 6, 2014·The Cochrane Database of Systematic Reviews·Paulien G de JongSaskia Middeldorp
Dec 15, 2019·Journal of Basic and Clinical Physiology and Pharmacology·Julaeha JulaehaAndi Hermansyah
Feb 23, 2020·Journal of Periodontology·I-Ching WangHom-Lay Wang
Jun 10, 2020·Genes, Brain, and Behavior·Richard Lathe, David St Clair
Aug 2, 2019·International Journal of Molecular Sciences·Sadayuki HashiokaMasatoshi Inagaki
Aug 24, 2017·International Clinical Psychopharmacology·Tammie Lee Demler, Kimberly B Mulcahy
Nov 13, 2020·Special Care in Dentistry : Official Publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry·Fernando Valentim BitencourtPatricia Daniela Melchiors Angst
Jan 23, 2021·International Journal of Environmental Research and Public Health·Ewa Pająk-ŁysekJoanna Zarzecka
Mar 12, 2019·La Presse médicale·Frederic DenisBenoit Trojak
Apr 17, 2021·Acta Psychiatrica Scandinavica·Elizabeth TurnerJasper Palmier-Claus
Aug 28, 2021·The Journal of Nervous and Mental Disease·Anna ComparelliMaurizio Pompili

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here